Eli Lilly launches insulin device for diabetes patients

Drug firm Eli Lilly and Company today said it has launched an insulin delivery device 'HumaPen Luxura HD' for patients suffering with diabetes.

The new dosing feature enhances safety and accuracy in maintaining blood sugar levels for patients, especially children suffering from insulin dependent diabetes (type 1 diabetes), Eli Lilly said in a statement.

"For children with type 1 diabetes, their journey can often be overwhelming and difficult to manage. We are pleased to introduce Luxura HD which provides type 1 patients with the confidence and assurance of an accurate delivery of insulin," Eli Lilly CMD Sandeep Gupta said.

According to the International Diabetes Federation (IDF), in 2010, approximately 3.80 lakh children in India between the Age group 0-14 years are projected to be suffering with type 1 diabetes.

Luxura HD, a reusable pen, delivers 0.5 to 30 units of insulin in half-unit increments and is for use with Lilly insulins. The product is priced at Rs 3,500 across the country, the company said.